Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Will Federal Legalization Occur in Time to Save Aurora Cannabis Stock?

By Dana Blankenhorn, InvestorPlace Contributor
ACB stock needs enough cash to reach 2021, when the market for recreational marijuana may open wider in the U.S.

Don’t Expect a Sharp Reversal in Aurora Cannabis Stock

By Faisal Humayun, InvestorPlace Contributor
Investors should expect medicinal cannabis growth to slow, extending the cash burn of ACB stock. For now, long-term investors should avoid it.

Why Investors Should Continue to Avoid Cronos Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
Long-term upside in CRON stock is compelling, but the bull thesis lacks conviction and clarity at the current moment.

What Canopy Growth Stock Needs to Rally

By Vince Martin, InvestorPlace Contributor
CGC stock is in decline, touching an 18-month low this week. The pressure on Canopy Growth stock will continue until the company responds.

Should Contrarian Investors Buy Aurora Cannabis Stock in October?

By Tezcan Gecgil, InvestorPlace Contributor
ACB stock's struggle with profitability reflects the overall headwinds faced by the entire cannabis industry.

7 Marijuana Stocks With Critical Levels to Watch

By Mark Putrino, CMT
Each of these seven marijuana stocks can teach a valuable lesson into how to use technical analysis to identify important levels.

Cannabis Stocks: Be Ready for the Next Catalyst

By InvestorPlace Research Staff
A new bill making its way through Congress is set to upend this outdated legal regime and usher in the next wave of growth in cannabis stocks.

Cannabis Stocks: We’ve Collected our First Cannabis Cash!

By InvestorPlace Research Staff
Matt McCall's strategy harnesses the growth of cannabis stocks and combines it with the income available from covered calls.

The Tables Could Soon Turn Back in Favor of Tilray Stock

By James Brumley, InvestorPlace Feature Writer
Tilray stock has been beaten to a pulp, like most other pot stocks. But, there's a nuance here that could readily reignite TLRY shares.

VIDEO: Invest in Emerging Markets Stocks to Balance Your Portfolio

By InvestorPlace Staff
Invest in emerging markets stocks to balance your portfolio and position yourself for long-term growth. Tune into "Moneyline" for more.

Marijuana Stocks: How to Profit Twice

By InvestorPlace Research Staff
Use this proven strategy to boost your returns in an absolutely massive investing theme: marijuana legalization.

Aurora Cannabis Has Become a ‘Blood in the Streets’ Opportunity

By Ian Cooper, InvestorPlace Contributor
Aurora Cannabis (ACB) stock has continously overpromised and underdelievered, but 'Cannabis 2.0' could be a major turning point for ACB stock holders.

Canopy Growth Emerges as Top ‘Cannabis 2.0’ Stock

By Ian Cooper, InvestorPlace Contributor
Canopy Growth stock is down from its previous highs, but CGC stock is well-positioned for the next leg of cannabis trends.

3 Marijuana Stocks Better Than Aurora Cannabis

By Wayne Duggan, InvestorPlace Contributor
Popular marijuana stocks like Aurora have taken a beating in recent months as market enthusiasm has died down and reality has set in about growth and regulatory challenges. Today, the best cannabis plays may be under-the-radar stocks.

Will Cannabis 2.0 Save Canopy Growth Stock?

By Mark Putrino, CMT
Will Cannabis 2.0 be enough to save CGC? The management of the company believes that it will be a major catalyst for CGC stock

It’s Finally Time to Consider Buying Canopy Growth Stock

By Chris Tyler, InvestorPlace Contributor
After initially recommending investors stay on the sidelines with CGC, evidence is building that they should now consider purchasing shares.

Cronos Group Stock May Get Boost From Cannabinoid Production

By Mark Putrino, CMT
Cronos may have an advantage in cannabinoid production, due to a strategic partnership. That could help CRON stock.

The Correction Is a Solid Opportunity to Buy Hexo Stock

By Ian Cooper, InvestorPlace Contributor
Earlier in the year, you would've needed a good psychiatrist if you purchased HEXO stock at its lofty levels. But now? Hexo is ripe for the picking.

Cannabis Stocks: How to Earn a 100% Yield Next Year … No Joke

By InvestorPlace Research Staff
Thanks to a once-in-a-decade anomaly in the business world, there’s currently an investment offering 100%+ annual yields in the cannabis sector.
Load More